Search
Leader | 00000nz a2200037n 45 0 | ||
---|---|---|---|
001 | WKP|Q80408054 (VIAF cluster) (Authority/Source Record) | ||
003 | WKP | ||
005 | 20241221010855.0 | ||
008 | 241221nneanz||abbn n and d | ||
035 | ‡a (WKP)Q80408054 | ||
024 | ‡a 0000-0001-6050-7354 ‡2 orcid | ||
024 | ‡a 23501529300 ‡2 scopus | ||
035 | ‡a (OCoLC)Q80408054 | ||
100 | 0 | ‡a P Cabrera Roldán ‡c researcher ‡9 en | |
400 | 0 | ‡a P Cabrera Roldán ‡c wetenschapper ‡9 nl | |
670 | ‡a Author's Evidence-based estimation and radiotherapy utilisation rate in Andalusia | ||
670 | ‡a Author's Genetic variations in genes involved in testosterone metabolism are associated with prostate cancer progression: A Spanish multicenter study. | ||
670 | ‡a Author's Health related quality of life and late side effects of long-term survivors of Ewing's sarcoma of bone | ||
670 | ‡a Author's Intraethnic variation in steroid-5-alpha-reductase polymorphisms in prostate cancer patients: a potential factor implicated in 5-alpha-reductase inhibitor treatment | ||
670 | ‡a Author's Myeloablative therapy against high risk Ewing's sarcoma: A single institution experience and literature review | ||
670 | ‡a Author's Prognostic factors for overall survival in paediatric patients with Ewing sarcoma of bone treated according to multidisciplinary protocol | ||
670 | ‡a Author's Role of radiation therapy in the multidisciplinary management of Ewing's Sarcoma of bone in pediatric patients: An effective treatment for local control | ||
670 | ‡a Author's Single nucleotide polymorphisms in DNA repair genes as risk factors associated to prostate cancer progression | ||
909 | ‡a (scopus) 23501529300 ‡9 1 | ||
909 | ‡a (orcid) 0000000160507354 ‡9 1 | ||
919 | ‡a singlenucleotidepolymorphismsindnarepairgenesasriskfactorsassociatedtoprostatecancerprogression ‡A Single nucleotide polymorphisms in DNA repair genes as risk factors associated to prostate cancer progression ‡9 1 | ||
919 | ‡a prognosticfactorsforoverallsurvivalinpaediatricpatientswithewingsarcomaofbonetreatedaccordingtomultidisciplinaryprotocol ‡A Prognostic factors for overall survival in paediatric patients with Ewing sarcoma of bone treated according to multidisciplinary protocol ‡9 1 | ||
919 | ‡a myeloablativetherapyagainsthighriskewingssarcomaasingleinstitutionexperienceandliteraturereview ‡A Myeloablative therapy against high risk Ewing's sarcoma: A single institution experience and literature review ‡9 1 | ||
919 | ‡a intraethnicvariationinsteroid5alphareductasepolymorphismsinprostatecancerpatientsapotentialfactorimplicatedin5alphareductaseinhibitortreatment ‡A Intraethnic variation in steroid-5-alpha-reductase polymorphisms in prostate cancer patients: a potential factor implicated in 5-alpha-reductase inhibitor treatment ‡9 1 | ||
919 | ‡a healthrelatedqualityoflifeandlatesideeffectsoflongtermsurvivorsofewingssarcomaofbone ‡A Health related quality of life and late side effects of long-term survivors of Ewing's sarcoma of bone ‡9 1 | ||
919 | ‡a geneticvariationsingenesinvolvedintestosteronemetabolismareassociatedwithprostatecancerprogressionaspanishmulticenterstudy ‡A Genetic variations in genes involved in testosterone metabolism are associated with prostate cancer progression: A Spanish multicenter study. ‡9 1 | ||
919 | ‡a evidencebasedestimationandradiotherapyutilisationrateinandalusia ‡A Evidence-based estimation and radiotherapy utilisation rate in Andalusia ‡9 1 | ||
919 | ‡a roleofradiationtherapyinthemultidisciplinarymanagementofewingssarcomaofboneinpediatricpatientsaneffectivetreatmentforlocalcontrol ‡A Role of radiation therapy in the multidisciplinary management of Ewing's Sarcoma of bone in pediatric patients: An effective treatment for local control ‡9 1 | ||
996 | ‡2 BNE|XX5532896 | ||
996 | ‡2 JPG|500026070 | ||
996 | ‡2 JPG|500037303 | ||
996 | ‡2 LC|nb2014027567 | ||
996 | ‡2 DNB|1057355682 | ||
996 | ‡2 BNE|XX849338 | ||
996 | ‡2 BLBNB|000515551 | ||
996 | ‡2 BNE|XX5346472 | ||
996 | ‡2 DNB|1161825843 | ||
996 | ‡2 SUDOC|255433743 | ||
996 | ‡2 SUDOC|057518076 | ||
996 | ‡2 J9U|987012502448605171 | ||
996 | ‡2 BNF|18066622 | ||
996 | ‡2 ISNI|0000000510851631 | ||
996 | ‡2 ISNI|0000000059226013 | ||
996 | ‡2 LC|no2016027244 | ||
996 | ‡2 DNB|1195228546 | ||
996 | ‡2 BIBSYS|98070944 | ||
996 | ‡2 BNC|981058512161606706 | ||
996 | ‡2 ISNI|0000000046749392 | ||
996 | ‡2 DNB|1057709417 | ||
996 | ‡2 BNF|13201654 | ||
996 | ‡2 LC|n 84076373 | ||
996 | ‡2 RERO|A018425162 | ||
996 | ‡2 LC|no2009035700 | ||
996 | ‡2 ISNI|0000000444631349 | ||
996 | ‡2 LC|n 2003098577 | ||
996 | ‡2 ISNI|0000000457168410 | ||
996 | ‡2 LC|n 2012035223 | ||
996 | ‡2 BNE|XX6082102 | ||
996 | ‡2 BNE|XX912163 | ||
996 | ‡2 DNB|1157166709 | ||
996 | ‡2 SZ|170853381 | ||
996 | ‡2 ISNI|0000000443607689 | ||
996 | ‡2 ISNI|0000000037323680 | ||
996 | ‡2 LC|no 97070619 | ||
996 | ‡2 DNB|1055807233 | ||
996 | ‡2 LIH|LNB:DTFP;=BK | ||
996 | ‡2 ISNI|0000000066385661 | ||
996 | ‡2 ISNI|000000003531561X | ||
996 | ‡2 RERO|A003366867 | ||
996 | ‡2 BNC|981058611981306706 | ||
996 | ‡2 BNC|981058527875906706 | ||
996 | ‡2 DNB|143852353 | ||
996 | ‡2 BNE|XX5297678 | ||
996 | ‡2 BNE|XX1041398 | ||
996 | ‡2 BNE|XX6040509 | ||
996 | ‡2 BNCHL|10000000000000000138350 | ||
996 | ‡2 JPG|500016834 | ||
996 | ‡2 ISNI|0000000408528010 | ||
996 | ‡2 LC|no2022022682 | ||
996 | ‡2 LC|n 96029070 | ||
996 | ‡2 LC|n 2001039479 | ||
997 | ‡a 0 0 lived 0 0 ‡9 1 |